Alembic makes executive appointmentNilesh Wadhwa, head of international business and strategy, has been designated as senior management personnel. Fresenius Kabi, Formycon secure U.S. license date for proposed Stelara biosimilarThe proposed Stelara biosimilar is a human monoclonal antibody for treatment of immune-mediated disorders. Lupin launches generic HandiHaler, receives FDA OK for 2 generics The company also has received FDA approval for generic Toprol-XL tablets and generic Bromday. Novartis spin-off of Sandoz generics drug unit to occur on or around Oct. 4 Novartis said it is confident that the spin-off is in the best interests of shareholders. Xiromed launches first generic of Balcoltra Xiromed's Joyeaux is an oral contraceptive. Aurobindo gets FDA OK for generic Firazyr Icatibant injection is indicated for treatment of acute attacks of hereditary angioedema in adults 18 years of age and older. Glenmark obtains FDA nod for generic Protopic Protopic Ointment had a market value of approximately $15.4 million for the 12 month period ending June 2023, per IQVIA. Upsher-Smith debuts generic Pepcid Famotidine Oral Suspension had a market value of approximately $73 million for the 12 months ending June 2023, per IQVIA. Lupin obtains FDA OK for generic Doryx Generic Doryx is a tetracycline-class antimicrobial indicated as adjunctive therapy for severe acne. Lupin receives FDA OK for generic Derma Smoothe/FS Fluocinolone acetonide oil is used in adult patients for psoriasis of the scalp. First Previous 57 58 59 60 61 Next Last
